2013
DOI: 10.4161/cc.27396
|View full text |Cite
|
Sign up to set email alerts
|

Rapamycin induces pluripotent genes associated with avoidance of replicative senescence

Abstract: Primary rodent cells undergo replicative senescence, independent from telomere shortening. We have recently shown that treatment with rapamycin during passages 3-7 suppressed replicative senescence in rat embryonic fibroblasts (REFs), which otherwise occurred by 10-14 passages. Here, we further investigated rapamycin-primed cells for an extended number of passages. Rapamycin-primed cells continued to proliferate without accumulation of senescent markers. Importantly, these cells retained the ability to undergo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

4
14
0
2

Year Published

2014
2014
2021
2021

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 25 publications
(20 citation statements)
references
References 141 publications
4
14
0
2
Order By: Relevance
“…Our study is consistent with previous findings. As a key drug in our experiments, rapamycin is a highly specific inhibitor of mTORC1 and has been used as a clinical immunosuppressant in organ transplantation and as an antiangiogenic agent in clinical trials for treatment of cancers and other vascular diseases [44, 45]. Interestingly, rapamycin has been reported to inhibit tumor angiogenesis through impairment of HIF-1α/VEGF production in some human cancer cell lines [46], which is consistent with our experimental results.…”
Section: Discussionsupporting
confidence: 80%
“…Our study is consistent with previous findings. As a key drug in our experiments, rapamycin is a highly specific inhibitor of mTORC1 and has been used as a clinical immunosuppressant in organ transplantation and as an antiangiogenic agent in clinical trials for treatment of cancers and other vascular diseases [44, 45]. Interestingly, rapamycin has been reported to inhibit tumor angiogenesis through impairment of HIF-1α/VEGF production in some human cancer cell lines [46], which is consistent with our experimental results.…”
Section: Discussionsupporting
confidence: 80%
“…oct-4, sox-2 and nanog, which is unrelated to autophagy. 34 The lack of specificity of rapamycin and other chemical agents, such as chloroquine, has been acknowledged and might be the most important weakness in many autophagy reports. 35,36 Chloroquine is an anti-malaria drug, which blocks lysosome function and has therefore a major impact on cell growth and survival.…”
Section: Discussionmentioning
confidence: 99%
“…The mammalian target of rapamycin (mTOR) pathway may represent another important biological mechanism linking telomeric aging to obesity, because mTOR pathway integrates insulin and nutrient signaling in numerous cell types and enhanced mTOR signaling has been implicated in cellular senescence. [31-33] Moreover, hyperactivity of the mTOR signaling has been associated with obesity and its related traits such as insulin resistance, type 2 diabetes, and cardiovascular diseas [34-37]. Furthermore, rapamycin slows down aging, prevents age-related diseases and extends maximal lifespan in mice [37].…”
Section: Discussionmentioning
confidence: 99%